← Leaderboards
Hudson H Freeze
Burnham Institute For Medical Research
$21,287,214
Attributed
$22,037,165
Total exposure
21
Grants
15
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$22,037,165 · 21
By mechanism
R01$15,988,358 · 6
U54$2,867,613 · 2
R21$1,831,082 · 4
RC1$999,935 · 1
P01$264,994 · 1
P41$40,183 · 4
Top collaborators
- Mark Andrew Lehrman2 shared
- Kirsten C Sadler Edepli2 shared
- Richard Steet2 shared
Others in their field
Top investigators on “Glycosylation”
- John M Lachin · George Washington University$134,552,372
- David M Nathan · Massachusetts Institute Of Technology$122,159,340
- Rose A Gubitosi-Klug · Case Western Reserve University$60,881,424
- Rohit Varma · University Of Southern California$43,479,151
- Anastassios G Pittas · Tufts Medical Center$32,774,287
- Ajit P Varki · University Of California San Diego$22,836,403
Research focus
GlycosylationProteinsCellsPolysaccharidesCongenital DisordersLinkMannoseMutationBaseGenesAffectGeneticPathway InteractionsAllelesComplexSerumTransferrinEnzymesBiochemicalMolecularPhenotypeDefectProtein-Losing EnteropathiesGolgi Apparatus
Grant awards (62)
New Congenital Disorders of Glycosylation: Therapy and Models$809,568
R01 · FY2025 · DK · contact PI
New Congenital Disorders of Glycosylation: Therapy and Models$809,566
R01 · FY2024 · DK · contact PI
Diagnosis & Biomarker Discovery Project$572,981
U54 · FY2023 · NS · contact PI
New Congenital Disorders of Glycosylation: Therapy and Models$546,107
R01 · FY2022 · DK · contact PI
Diagnosis & Biomarker Discovery Project$408,029
U54 · FY2022 · NS · contact PI
New Congenital Disorders of Glycosylation: Therapy and Models$563,267
R01 · FY2021 · DK · contact PI
Diagnosis & Biomarker Discovery Project$452,410
U54 · FY2021 · NS · contact PI
Diagnosis & Biomarker Discovery Project$606,190
U54 · FY2020 · NS · contact PI
New Congenital Disorders of Glycosylation: Therapy and Models$559,835
R01 · FY2020 · DK · contact PI
Diagnosis & Biomarker Discovery Project$828,003
U54 · FY2019 · NS · contact PI
New Congenital Disorders of Glycosylation: Therapy and Models$546,107
R01 · FY2019 · DK · contact PI
New Congenital Disorders of Glycosylation: Therapy and Models$412,576
R01 · FY2018 · DK · contact PI
New Congenital Disorders of Glycosylation: Therapy and Models$412,576
R01 · FY2017 · DK · contact PI
New Congenital Disorders of Glycosylation: Therapy and Models$412,576
R01 · FY2016 · DK · contact PI
New Congenital Disorders of Glycosylation: Therapy and Models$412,576
R01 · FY2015 · DK · contact PI
New Congenital Disorders of Glycosylation: Therapy and Models$436,326
R01 · FY2014 · DK · contact PI
An Expanded Spectrum for Congenital Disorders of Glycosylation$236,925
R21 · FY2014 · HD · contact PI
Carbohydrate Deficient Glycoprotein Syndromes: Models and Therapy$376,779
R01 · FY2013 · DK · contact PI
An Expanded Spectrum for Congenital Disorders of Glycosylation$292,500
R21 · FY2013 · HD · contact PI
Factors Determining Protein Losing Enteropathy$472,725
R01 · FY2012 · HL · contact PI
Carbohydrate Deficient Glycoprotein Syndromes: Models and Therapy$390,445
R01 · FY2012 · DK · contact PI
Factors Determining Protein Losing Enteropathy$477,500
R01 · FY2011 · HL · contact PI
Carbohydrate Deficient Glycoprotein Syndromes: Models and Therapy$382,435
R01 · FY2011 · DK · contact PI
Novel Therapy for a Human Glycosylation Disorder$217,333
R21 · FY2011 · HD · contact PI
Testing Substrate-Flux Therapies for Glycosylation Disorders using Zebrafish$499,941
RC1 · FY2010 · HD · contact PI
Factors Determining Protein Losing Enteropathy$477,500
R01 · FY2010 · HL · contact PI
Carbohydrate Deficient Glycoprotein Syndromes: Models and Therapy$477,500
R01 · FY2010 · DK · contact PI
Novel Therapy for a Human Glycosylation Disorder$266,562
R21 · FY2010 · HD · contact PI
Testing Substrate-Flux Therapies for Glycosylation Disorders using Zebrafish$499,994
RC1 · FY2009 · HD · contact PI
Factors Determining Protein Losing Enteropathy$477,500
R01 · FY2009 · HL · contact PI
Therapeutic Inhibitors of Phosphomannose Isomerase$25,000
R03 · FY2008 · MH · contact PI
ANALYSIS OF N-LINKED GLYCOFORM VARIANTS IN CONGENITAL DISORDERS OF GLYCOSYLATION$9,724
P41 · FY2008 · RR · contact PI
NOVEL CARBOXYLATED GLYCANS IN CELL ADHESION$8,075
P41 · FY2008 · RR · contact PI
Carbohydrate Deficient Glycoprotein Syndromes$358,583
R01 · FY2007 · DK · contact PI
ANALYSIS OF N-LINKED GLYCOFORM VARIANTS IN CONGENITAL DISORDERS OF GLYCOSYLATION$16,160
P41 · FY2007 · RR · contact PI
NOVEL CARBOXYLATED GLYCANS IN CELL ADHESION$6,224
P41 · FY2007 · RR · contact PI
Carbohydrate Deficient Glycoprotein Syndromes$369,293
R01 · FY2006 · DK · contact PI
Novel Carboxylated Glycans in Cell Adhesion$344,158
R01 · FY2006 · CA · contact PI
Basis of Post-Fontan Protein Losing Enteropathy$186,512
R21 · FY2006 · HL · contact PI
Carbohydrate Deficient Glycoprotein Syndromes$378,180
R01 · FY2005 · DK
Novel Carboxylated Glycans in Cell Adhesion$352,440
R01 · FY2005 · CA
Basis of Post-Fontan Protein Losing Enteropathy$334,250
R21 · FY2005 · HL
Novel Approaches to Mend Deficient Glycosylation$320,640
R01 · FY2005 · DK
Carbohydrate Deficient Glycoprotein Syndromes$378,180
R01 · FY2004 · DK
Novel Carboxylated Glycans in Cell Adhesion$352,440
R01 · FY2004 · CA
Novel Approaches to Mend Deficient Glycosylation$320,640
R01 · FY2004 · DK
Human Glycosylation Disorders 2003$10,000
R13 · FY2004 · DK
Novel Approaches to Mend Deficient Glycosylation$372,480
R01 · FY2003 · DK
Novel Carboxylated Glycans in Cell Adhesion$352,440
R01 · FY2003 · CA
Novel Carboxylated N-Glycans that Mediate Inflammation$148,500
R21 · FY2003 · GM
CARBOHYDRATE DEFICIENT GLYCOPROTEIN SYNDROMES$76,320
R01 · FY2003 · DK
Novel Carboxylated Glycans in Cell Adhesion$374,690
R01 · FY2002 · CA
CARBOHYDRATE DEFICIENT GLYCOPROTEIN SYNDROMES$361,102
R01 · FY2002 · DK
Novel Carboxylated N-Glycans that Mediate Inflammation$148,500
R21 · FY2002 · GM
CARBOHYDRATE DEFICIENT GLYCOPROTEIN SYNDROMES$126,555
R01 · FY2002 · DK
MANNOSE IN MAMMALIAN GLYCOPROTEIN SYNTHESIS$492,068
R01 · FY2001 · GM
CARBOHYDRATE DEFICIENT GLYCOPROTEIN SYNDROMES$350,673
R01 · FY2001 · DK
MANNOSE IN MAMMALIAN GLYCOPROTEIN SYNTHESIS$488,181
R01 · FY2000 · GM
CARBOHYDRATE DEFICIENT GLYCOPROTEIN SYNDROMES$340,543
R01 · FY2000 · DK
ENVIRONMENTAL MAPPING OF GLYCOSYL TRANSFERASES IN GOLGI$264,994
P01 · FY2000 · CA
MANNOSE IN MAMMALIAN GLYCOPROTEIN SYNTHESIS$25,288
R01 · FY2000 · GM
CONGENITAL DISORDERS OF GLYCOSYLATION 2000$10,000
R13 · FY2000 · DK